What is Apogee Therapeutics, Inc.'s net investment in lease?

Apogee Therapeutics, Inc. (APGE) reported net investment in lease of $7.71M in Q1 2026.

How has Apogee Therapeutics, Inc.'s net investment in lease changed year-over-year?

Apogee Therapeutics, Inc.'s net investment in lease decreased by 33.0% year-over-year, from $11.51M to $7.71M.

What is the long-term trend for Apogee Therapeutics, Inc.'s net investment in lease?

Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s net investment in lease has grown at a 97.9% compound annual growth rate (CAGR), from $2.22M to $8.69M.

Apogee Therapeutics, Inc. APGE Net Investment in Lease

Net Investment in Lease at other companies

Protagonist TherapeuticsPTGX

——

Summit TherapeuticsSMMT

——

Arrowhead ResearchARWR

——

IQVIAIQV

——

ALN

Alnylam PharmaceuticalsALNY

——

Ionis PharmaceuticalsIONS

——

Other financials

Income statement

See full

Operating income-$82.8M-31.2%

Net income-$74.1M-33.9%

EPS (diluted)-$1.06-11.6%

Balance sheet

See full

Cash & equivalents$451.8M+323%

Total debt$8.0M-31.9%

Total assets$1.3B+81.1%

Cash flow

See full

Operating cash flow-$55.6M-14.6%

CapEx$62.0K—

Free cash flow-$62.8M+7.3%

Valuation

See full

Market cap$6.81B+189%

Enterprise value$6.37B+181%

Returns & leverage

See full

Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s net investment in lease?: Apogee Therapeutics, Inc. (APGE) reported net investment in lease of $7.71M in Q1 2026.
How has Apogee Therapeutics, Inc.'s net investment in lease changed year-over-year?: Apogee Therapeutics, Inc.'s net investment in lease decreased by 33.0% year-over-year, from $11.51M to $7.71M.
What is the long-term trend for Apogee Therapeutics, Inc.'s net investment in lease?: Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s net investment in lease has grown at a 97.9% compound annual growth rate (CAGR), from $2.22M to $8.69M.